TP53 and breast cancer: We investigated the potential mechanism of Z734 cytotoxic activity against MCF–7 cells, which inhibits cell proliferation and migration of breast cancer by inducing the ubiquitination–based degradation of ERK2 and can further regulate the HERC3/p53 signal in breast cancer.